See also this year's filing and all EDGAR filings for this company.
PDF Report 0001689813_2018_Biohaven_Pharmaceutical_Holding_Co_Ltd.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 11, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Cal 2)': 3}} |
Graph
Absolute values for 0001689813, Biohaven Pharmaceutical Holding Co Ltd
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 136,665,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,344,000 |
| 3 | remainder_Assets | 7,879,000 |
| 4 | LiabilitiesCurrent | 9,429,000 |
| 5 | LiabilitiesNoncurrent | 1,467,000 |
| 6 | remainder_Liabilities | 4,021,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,141,000 |
| 9 | ResearchAndDevelopmentExpense | 89,441,000 |
| 10 | remainder_Expenses | 1,006,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -18,602,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 146,888,000 |
| 1 | Liabilities | 14,917,000 |
| 2 | Expenses | 108,588,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 131,971,000 |
| 5 | NetIncome | -127,190,000 |
| 6 | ComprehensiveNetIncome | -127,190,000 |
| 7 | BaseVar | 144,497,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.98 |
| 9 | EconomicCapitalRatio | 3.01 |
Edgar->Model Mapping
Feature Distribution
